Imagindairy and Ginkgo Bioworks Collaborate to Develop and Produce Animal-Free Non-Whey Dairy Proteins
HAIFA, Israel and BOSTON, March 26, 2024 /PRNewswire/ -- Imagindairy, an Israeli-based foodtech company developing sustainable and commercially viable animal-free dairy proteins, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership. Together, Ginkgo and Imagindairy aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner. This collaboration will leverage Ginkgo Protein Expression Services and Imagindairy's process development and scale-up expertise to accelerate the development of functional non-whey dairy proteins. This is a multi-year program, funded in part by a joint grant from the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.
- Together, Ginkgo and Imagindairy aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner.
- Imagindairy envisions a cutting-edge transition in the dairy industry that preserves the flavor, functionality and experience of dairy without relying on cows.
- With access to its own fully operational production lines, a first in the industry, Imagindairy is able to produce cost-effective dairy proteins at scale.
- Imagindairy and Ginkgo have partnered to design an optimized organism capable of cost-effectively producing non-whey dairy proteins.